Companies / Japan
Astellas Announces New Recovery Plan
October 2006 | Company Finance AlertObservers have welcomed a new five-year plan announced by third-ranked Japanese drugmaker Astellas. However, despite the warm reception, the announcements contain little to dispel suspicions that the company faces short-term decline and is now a potential takeover target.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
